Contact Form

Name

Email *

Message *

Cari Blog Ini

Image

Srp Vacuna An In Depth Guide To The Meningitis Vaccine


Srp Vacuna

Srp Vacuna: An In-Depth Guide to the Meningitis Vaccine

What is the Meningococcal Vaccine?

The meningococcal vaccine, also known as the SrP vacuna, protects against bacterial meningitis. Meningitis is a serious infection of the membranes surrounding the brain and spinal cord that can lead to permanent disability or even death.

There are two different types of meningococcal vaccines: the conjugate vaccine (MCV) and the polysaccharide vaccine (MPSV).

  • The MCV vaccine is recommended for children and adolescents because it is more effective and longer-lasting than the MPSV vaccine.
  • The MPSV vaccine is recommended for adults who are at high risk of contracting meningococcal disease.

Who Should Get the Meningococcal Vaccine?

The meningococcal vaccine is recommended for all children and adolescents. The Centers for Disease Control and Prevention (CDC) recommends that children receive their first dose of the MCV vaccine at 11 or 12 years old and a booster dose at 16 or 17 years old.

The MPSV vaccine is recommended for adults who are at high risk of contracting meningococcal disease, including:

  • Travelers to countries where meningococcal disease is common
  • People who have a weakened immune system
  • People who live in close quarters, such as college students or military recruits

What are the Risks of the Meningococcal Vaccine?

The meningococcal vaccine is generally safe and well-tolerated. The most common side effects are redness, swelling, and pain at the injection site.

There is a very small risk of serious side effects, such as:

  • Meningitis
  • Encephalitis
  • Guillain-Barré syndrome

However, these side effects are very rare.

How Effective is the Meningococcal Vaccine?

The meningococcal vaccine is very effective at preventing meningococcal disease. The MCV vaccine is 99% effective at preventing serogroups A, C, W, and Y meningococcal disease.

The MPSV vaccine is 70-85% effective at preventing serogroups A, C, W, and Y meningococcal disease.

Conclusion

The meningococcal vaccine is a safe and effective way to protect against meningococcal disease. All children and adolescents should get the meningococcal vaccine, and adults who are at high risk of contracting meningococcal disease should also get the vaccine.


Comments